Adam Levinson

Adam Levinson is an accomplished medicinal chemist with a robust background in drug discovery and development. Currently serving as the Director of Medicinal Chemistry at Schrödinger since November 2019, Adam has advanced multiple high-impact oncology and neuroscience projects utilizing Schrödinger’s computational platform for structure-based drug design. Prior experience includes leading a medicinal chemistry team at Eli Lilly and contributing to the discovery of small molecule inhibitors for autoimmune diseases, delivering a development candidate that entered Phase 1 clinical trials. Adam's academic background encompasses a Ph.D. in Organic Chemistry from the Memorial Sloan-Kettering Tri-Institutional Graduate Program, supplemented by a Master's degree from Columbia University and a Bachelor's degree in Chemistry from Emory University.